Religare Health Trust kicks off $448 million Singapore IPO

The business trust is sponsored by Indian hospital operator Fortis Healthcare and promises a dividend yield of at least 6%. Meanwhile, electronics retailer Courts Asia starts bookbuilding for an IPO of around $100 million.
<div style="text-align: left;">
Fortis Healthcare's colorectal centre in Singapore is the first of its kind in Southeast Asia
</div>
<div style="text-align: left;"> Fortis Healthcare's colorectal centre in Singapore is the first of its kind in Southeast Asia </div>

Religare Health Trust RHT, a business trust sponsored by India-listed hospital operator Fortis Healthcare, has started bookbuilding for a Singapore initial public offering of up to S$550.4 million $448 million.

The deal could become the second-biggest listing in Singapore this year after Far East Hospitality Trust, which raised $527 million through an IPO in mid-August, and will give Southeast Asia another boost in its quest to beat Hong Kong as the most active region for Asian IPOs this year. Based on the IPO activity in the first nine months of this year, this is a competition that Southeast Asia looks to be winning quite comfortably thanks to...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222